<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="13154">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01746407</url>
  </required_header>
  <id_info>
    <org_study_id>09DELK12</org_study_id>
    <nct_id>NCT01746407</nct_id>
  </id_info>
  <brief_title>Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis</brief_title>
  <acronym>EMOS</acronym>
  <official_title>Observational Study to Procure Human Specimens for Use in the Diagnosis and Management of Sepsis and Other Related Conditions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Diagnostics Division</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Diagnostics Division</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Procure blood specimens from individuals presenting to the emergency department (ED) with
      signs and /or symptoms of systemic infection or sepsis.  The samples will be used for
      research and development activities related to sepsis, infections, etc.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Progression of infection to severe sepsis</measure>
    <time_frame>72 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assessment of the progression of infection to severe sepsis in an ED population who present with signs or symptoms of infection.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Infection</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma and serum samples stored @ -70C.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Presentation to an emergency department
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 yrs of age or older

          -  For women of child bearing years: not known to be pregnant

          -  Blood culture ordered as part of the ED, ICU (or equivalent) or hospital floor stay.

        Exclusion Criteria:

          -  Previously enrolled in this study

          -  Vulnerable individual

          -  Unable to speak and/or understand English
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Greg S Martin, MD, M.Sc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Greg S Martin, MD, M.Sc</last_name>
    <phone>404-616-0148</phone>
    <email>greg.martin@emory.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Greg S Martin, MD, M.Sc.</last_name>
      <phone>404-616-0148</phone>
      <email>greg.martin@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Jonathan Sevransky, MD, MHS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Grady Memorial Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Greg S Martin, MD</last_name>
      <phone>404-616-0148</phone>
      <email>greg.martin@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Greg S Martin, MD, M.Sc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 18, 2013</lastchanged_date>
  <firstreceived_date>December 7, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Emergency Department</keyword>
  <keyword>Infection</keyword>
  <keyword>Sepsis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
